Cordlife’s business reset may give minority shareholders the best chance to bail out fast
There is much uncertainty for the company’s minority shareholders amid substantial shareholder dispute, possible lawsuits
CORDLIFE Group has been granted a reprieve, following the Ministry of Health’s (MOH) notice on Aug 29 that it could resume some cord-blood banking services in a “controlled manner” from Sep 15.
Although this signals that things could be getting back on track, some upcoming personnel departures show that the company is not quite out of the woods yet – and investors may need to look for an exit, fast.
The counter has been in dire straits since Cordlife’s Singapore operations were suspended for six months from collecting, processing, testing or storing new cord-blood units in December last year.
TRENDING NOW
CSE Global independent director quits after clashes with chairman Eugene Lai over board refresh
What’s wrong with Orchard Road? Experts weigh in on the street’s cachet and its future
‘I felt like dying’: Thai Singha beer scion speaks up after disclosure of alleged sexual abuse
Rare brutalist Singapore house opens to the public before changing hands